AnalystsLeland GershellLeland Gershell's Stock Forecasts
AnalystsLeland Gershell
Analyst Ranking
Top 9%
#412 out of 4880 analysts
Average Return
+15.97%
Win Rate
36%45 out of 124
Risk vs Reward
Poor
Good
Leland Gershell's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Soleno Therapeutics IncSLNO | +1,687.66% | $2.35 | $42.01 | 2023-03-23 - 2024-03-22 | Buy |
Soleno Therapeutics IncSLNO | +978.37% | $4.90 | $52.84 | 2023-09-14 - 2024-09-13 | Buy |
Soleno Therapeutics IncSLNO | +718.29% | $5.03 | $41.16 | 2023-05-24 - 2024-05-24 | Buy |
Crinetics Pharmaceuticals IncCRNX | +206.35% | $17.32 | $53.06 | 2023-08-30 - 2024-08-30 | Buy |
Xeris Biopharma Holdings IncXERS | +154.75% | $2.21 | $5.63 | 2024-03-27 - 2025-03-27 | Buy |
Leland Gershell Analyst Color
Get additional color on Leland Gershell's coverage of popular stocks
Leland Gershell's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Xeris Biopharma Holdings IncXERS | 2 | Buy | $7.00 | +43.44% | Maintains | 8 days ago |
Argenx SeARGX | 7 | Buy | $708.00 | +25.17% | Maintains | 8 days ago |
Quince Therapeutics IncQNCX | 1 | Buy | $10.00 | +1,076.47% | Initiates Coverage On | 2 months ago |
Trevi Therapeutics IncTRVI | 3 | Buy | $20.00 | +207.69% | Maintains | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $98.00 | +65.35% | Upgrades | 3 months ago |
Rhythm Pharmaceuticals IncRYTM | 1 | Buy | $76.00 | +26.81% | Initiates Coverage On | 5 months ago |
Ascendis Pharma AASND | 8 | Buy | $180.00 | +14.21% | Maintains | 6 months ago |
Dianthus Therapeutics IncDNTH | 2 | Buy | $52.00 | +164.09% | Maintains | 6 months ago |
Ligand Pharmaceuticals IncLGND | 2 | Buy | $147.00 | +40.62% | Maintains | 6 months ago |
Veru IncVERU | 6 | Buy | $5.00 | +863.39% | Reiterates | 6 months ago |
Soleno Therapeutics IncSLNO | 8 | Buy | $73.00 | -2.68% | Maintains | 7 months ago |
Urogen Pharma LtdURGN | 8 | Buy | $40.00 | +447.20% | Reiterates | 7 months ago |
Immunovant IncIMVT | 3 | Buy | $53.00 | +266.53% | Maintains | 7 months ago |
Capricor Therapeutics IncCAPR | 4 | Buy | $43.00 | +355.51% | Maintains | 8 months ago |
Engene Holdings IncENGN | 2 | Buy | $30.00 | +769.57% | Reiterates | 8 months ago |
Sab Biotherapeutics IncSABS | 2 | Buy | $12.00 | +548.65% | Reiterates | 8 months ago |
Nucana PLCNCNA | 8 | Buy | $25.00 | +56,718.18% | Maintains | 8 months ago |
Viridian Therapeutics IncVRDN | 5 | Buy | $28.00 | +116.38% | Reiterates | 9 months ago |
Protara Therapeutics IncTARA | 3 | Buy | $25.00 | +683.70% | Maintains | 9 months ago |
Crinetics Pharmaceuticals IncCRNX | 7 | Buy | $73.00 | +133.67% | Reiterates | 9 months ago |
Lumos Pharma IncLUMO | 5 | Buy | $13.00 | +199.54% | Maintains | 9 months ago |
Calcimedica IncCALC | 5 | Buy | $20.00 | +900.00% | Maintains | 10 months ago |
Catalyst Pharmaceuticals IncCPRX | 3 | Buy | $29.00 | +19.00% | Reiterates | a year ago |
Essa Pharma IncEPIX | 1 | Buy | $17.00 | N/A | Maintains | a year ago |
Avalo Therapeutics IncAVTX | 1 | Buy | $35.00 | N/A | Upgrades | a year ago |
Cue Biopharma IncCUE | 1 | Buy | $10.00 | N/A | Maintains | a year ago |
Pds Biotechnology CorpPDSB | 3 | Buy | $20.00 | N/A | Maintains | 2 years ago |
Milestone Pharmaceuticals IncMIST | 3 | Buy | $13.00 | N/A | Maintains | 2 years ago |
X4 Pharmaceuticals IncXFOR | 1 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Alnylam Pharmaceuticals IncALNY | 4 | Buy | $249.00 | N/A | Maintains | 2 years ago |
Clene IncCLNN | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Plx Pharma IncPLXPQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Buy | $140.00 | N/A | Initiates Coverage On | 3 years ago |
Grace Therapeutics IncGRCE | 3 | Buy | $36.00 | N/A | Initiates Coverage On | 3 years ago |
Opiant Pharmaceuticals IncOPNT | 1 | Buy | $42.00 | N/A | Initiates Coverage On | 3 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 4 years ago |
Windtree Therapeutics IncWINT | 1 | Buy | $7,200.00 | N/A | Initiates Coverage On | 4 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Casi Pharmaceuticals IncCASI | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 5 years ago |
Vaccinex IncVCNX | 2 | Buy | $1,470.00 | N/A | Maintains | 5 years ago |
Fresh Tracks Therapeutics IncFRTX | 1 | Buy | $5.00 | N/A | Initiates Coverage On | 5 years ago |
Acceleron Pharma IncXLRN | 1 | Buy | $112.00 | N/A | Maintains | 5 years ago |
Epizyme IncEPZM | 1 | Hold | $16.00 | N/A | Downgrades | 5 years ago |
Amarin Corp PLCAMRN | 5 | Hold | N/A | N/A | Upgrades | 5 years ago |
Trevena IncTRVN | 1 | Buy | $8,125.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.